Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nutt

Showing results (761-770 of 790) with videos related to

Pageof 79
Sort By:
Neuroimage. Clinical|June 7, 2020
Disturbances across whole brain networks during reward anticipation in an abstinent addiction populationLiam J Nestor, John Suckling, Karen D Ersche, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 11, 2015
Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological GamblersInge Mick, Jim Myers, Anna C Ramos, et al.
Neurology|September 30, 2010
A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2D M Kay, C F Stevens, T H Hamza, et al.
Journal of Psychopharmacology (Oxford, England)|September 4, 2010
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disordersS J Wilson, D J Nutt, C Alford, et al.
Neuroscience and Biobehavioral Reviews|April 9, 2013
Innovative solutions to novel drug development in mental healthT R Insel, V Voon, J S Nye, et al.
Journal of Psychopharmacology (Oxford, England)|August 9, 2013
Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depressionAnu Tammiste, Tao Jiang, Krista Fischer, et al.
JAMA Psychiatry|July 9, 2025
Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-AnalysisMichail Kalfas, Dimosthenis Tsapekos, Matthew Butler, et al.
Plos One|November 14, 2013
Personalized risk assessment of drug-related harm is associated with health outcomesAndrea A Jones, Fidel Vila-Rodriguez, William J Panenka, et al.
Psychopharmacology|February 26, 2016
Impulsivity in abstinent alcohol and polydrug dependence: a multidimensional approachEleanor M Taylor, Anna Murphy, Venkat Boyapati, et al.
Journal of Psychopharmacology (Oxford, England)|October 6, 2016
The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI descriptionJohn McGonigle, Anna Murphy, Louise M Paterson, et al.
Pageof 79

Showing results (761-770 of 790) with videos related to

Sort By:
Pageof 79
Neuroimage. Clinical|June 7, 2020
Disturbances across whole brain networks during reward anticipation in an abstinent addiction populationLiam J Nestor, John Suckling, Karen D Ersche, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 11, 2015
Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological GamblersInge Mick, Jim Myers, Anna C Ramos, et al.
Neurology|September 30, 2010
A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2D M Kay, C F Stevens, T H Hamza, et al.
Journal of Psychopharmacology (Oxford, England)|September 4, 2010
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disordersS J Wilson, D J Nutt, C Alford, et al.
Neuroscience and Biobehavioral Reviews|April 9, 2013
Innovative solutions to novel drug development in mental healthT R Insel, V Voon, J S Nye, et al.
Journal of Psychopharmacology (Oxford, England)|August 9, 2013
Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depressionAnu Tammiste, Tao Jiang, Krista Fischer, et al.
JAMA Psychiatry|July 9, 2025
Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-AnalysisMichail Kalfas, Dimosthenis Tsapekos, Matthew Butler, et al.
Plos One|November 14, 2013
Personalized risk assessment of drug-related harm is associated with health outcomesAndrea A Jones, Fidel Vila-Rodriguez, William J Panenka, et al.
Psychopharmacology|February 26, 2016
Impulsivity in abstinent alcohol and polydrug dependence: a multidimensional approachEleanor M Taylor, Anna Murphy, Venkat Boyapati, et al.
Journal of Psychopharmacology (Oxford, England)|October 6, 2016
The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI descriptionJohn McGonigle, Anna Murphy, Louise M Paterson, et al.
Pageof 79